Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
At first glance, planning a clinical supply chain for a biosimilar trial appears like getting ready for a traditional study. As in all clinical trials the supplies team is responsible for making sure the investigational biosimilar drug makes it to the right patient, at the right time and place. Yet these studies do present some unique challenges for clinical supply chain professionals. First among these differences is the sourcing of the comparator medication. A highly strategic sourcing strategy is necessary because these trials most often target biologic medicines that are high cost and in high demand. The popularity of these successful medications brings other unique challenges when designing effective blinding methods. This eBook outlines the top 4 differences in managing clinical supplies for biosimilar trials. These challenges make biosimilar studies anything but routine for clinical supply teams.